The OPTPRESS Trial
Feb 22, 2026
READ MORE
Should we be targeting a higher MAP in that subset of patients with sepsis who progress to shock? There is a high mortality in this group and an even ...
Selected Articles
Join the Newsletter
Receive updates in your inbox and start today!